This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Babylon Holdings 관리

관리 기준 확인 0/4

Babylon Holdings CEO는 Parsa Parsadoust, Jan2013 에 임명되었습니다 의 임기는 10.58 년입니다. 총 연간 보상은 $ 7.10M, 8.7% 로 구성됩니다. 8.7% 급여 및 91.3% 보너스(회사 주식 및 옵션 포함). 는 $ 101.18K 가치에 해당하는 회사 주식의 18.9% 직접 소유합니다. 101.18K. 경영진과 이사회의 평균 재임 기간은 각각 1.6 년과 2.3 년입니다.

주요 정보

Parsa Parsadoust

최고 경영자

US$7.1m

총 보상

CEO 급여 비율	8.7%
CEO 임기	10.6yrs
CEO 소유권	18.9%
경영진 평균 재임 기간	1.6yrs
이사회 평균 재임 기간	2.3yrs

최근 관리 업데이트

Recent updates

Babylon to execute 1-for-25 reverse share split

Nov 09

Babylon Holdings files to sell 145.89M Class A ordinary shares

Oct 17

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Sep 22

CEO 보상 분석

Parsa Parsadoust 의 보수는 Babylon Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2023	n/a	n/a	-US$256m
Dec 31 2022	US$7m	US$621k	-US$221m
Sep 30 2022	n/a	n/a	-US$213m
Jun 30 2022	n/a	n/a	-US$189m
Mar 31 2022	n/a	n/a	-US$96m
Dec 31 2021	US$651k	US$396k	-US$77m

보상 대 시장: Parsa 의 총 보상 ($USD 7.10M )은 US 시장( $USD 646.00K ).

보상과 수익: 회사가 수익성이 없는 동안 Parsa 의 보상이 증가했습니다.

CEO

Parsa Parsadoust (57 yo)

10.6yrs

테뉴어

US$7,103,722

보상

Dr. Ali Parsadoust is also knwon as Parsa, is the Founder of Babylon Healthcare Services Ltd. and serves as its Chief Executive Officer since January 2013 and its Chairman. He serves as Director of Babylon...

리더십 팀

이름	위치	테뉴어	보상	소유권
Ali Parsadoust	Founder	10.6yrs	US$7.10m	18.9% $ 101.2k
Paul-Henri Ferrand	Chief Operating Officer	less than a year	US$6.66m	0.55% $ 3.0k
David Humphreys	Chief Financial Officer	less than a year	데이터 없음	0.11% $ 571.7
Samira Lowman	Chief People Officer	2.3yrs	데이터 없음	데이터 없음
Mairi Johnson	Chief Partnerships Officer & Employee Director	6.3yrs	데이터 없음	0.0016% $ 8.6
Aron England	Chief Product Officer	less than a year	데이터 없음	데이터 없음

1.6yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 관리: BBLN.F 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ali Parsadoust	Founder	10.6yrs	US$7.10m	18.9% $ 101.2k
Mairi Johnson	Chief Partnerships Officer & Employee Director	7.9yrs	데이터 없음	0.0016% $ 8.6
Eugene Davis	Independent Director	less than a year	데이터 없음	데이터 없음
James Carlson	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
John Rowe	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
Arnold Milstein	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
Thomas Spann	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
Sean Slovenski	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
Mary Langowski	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
Molly Joseph	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음
David Warren	Independent Non Executive Director	1.9yrs	US$226.43k	0.00063% $ 3.4
Dennis Chornenky	Member of Executive Advisory Board	2.3yrs	데이터 없음	데이터 없음

2.3yrs

평균 재임 기간

68yo

평균 연령

경험이 풍부한 이사회: BBLN.F 의 이사회는 경험(평균 재직 기간 2.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

This company listing is no longer active

Babylon Holdings 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Babylon Holdings Limited Announces Board Changes

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

High number of new and inexperienced directors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Recent updates

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Holdings Limited Announces Board Changes

Babylon Holdings Limited announced that it expects to receive $34.5 million in funding from AlbaCore Capital LLP

First quarter 2023 earnings released: US$2.53 loss per share (vs US$5.94 loss in 1Q 2022)

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

Consensus revenue estimates decrease by 16%, EPS upgraded

Full year 2022 earnings: EPS exceeds analyst expectations

Babylon Holdings Limited to Report Q4, 2022 Results on Mar 09, 2023

Babylon Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

Consensus estimates of losses per share improve by 10%

Price target decreased to US$2.10

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

VNV (Cyprus) Limited Engages in Discussions with Babylon Holdings Limited

Babylon to execute 1-for-25 reverse share split

Babylon Holdings Limited announced that it has received $80 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited announced that it expects to receive $61.45 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Holdings files to sell 145.89M Class A ordinary shares

Babylon Holdings Limited to Report Q3, 2022 Results on Nov 10, 2022

Babylon Holdings Reportedly to Sell Meritage IPA Assets in Early 2023

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Babylon Receives Share Price Notice from the New York Stock Exchange Due to Non-Compliance with NYSE Rule 802.01C

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Babylon Holdings Limited Announces Chief Financial Officer Changes

Babylon gets new CFO

Babylon Holdings Denies Acquisition Rumors

Babylon Holdings jumps after report of potential sale process

Second quarter 2022 earnings: EPS misses analyst expectations

Babylon Holdings Limited Provides Guidance for the Twelve Months Ending December 31, 2022

Babylon Holdings Limited Announces Executive Changes

Babylon Holdings Limited, Annual General Meeting, Sep 14, 2022

Babylon Holdings Limited to Report Q2, 2022 Results on Aug 09, 2022

Babylon Holdings Limited Provides Earnings Guidance for the Year 2022

Babylon +2%, expects $100M savings per year

Consensus revenue estimates increase by 11%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Babylon Holdings Limited Revises Revenue Guidance for the Year 2022

Price target decreased to US$7.30

High number of new and inexperienced directors

Babylon Holdings Limited to Report Q1, 2022 Results on May 12, 2022

Consensus forecasts updated

Full year 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Babylon Holdings Limited to Report Q4, 2021 Results on Mar 10, 2022

Babylon Holdings Limited Announces Resignation of Stacy Saal as Chief Operating Officer, Effective February 12, 2022

Babylon Holdings: A Virtual Value-Based Care Leader With Upside

Babylon Holdings Limited (NYSE:BBLN) acquired DayToDay Health.

Babylon Holdings Limited Increases Revenue Guidance for the Full-Year 2022

Forecast to breakeven in 2024

High number of new and inexperienced directors

Babylon Launches AI in Rwanda in Next Step Towards Digitising Healthcare in Rwanda

Third quarter 2021 earnings released: US$0.08 loss per share

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령